A Randomized, Open-Label, Single-Dose, Four-Way Crossover Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System Versus IMITREX STATdose at Three Injection Sites in Healthy Adults.

Trial Profile

A Randomized, Open-Label, Single-Dose, Four-Way Crossover Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System Versus IMITREX STATdose at Three Injection Sites in Healthy Adults.

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Feb 2010

At a glance

  • Drugs Sumatriptan (Primary)
  • Indications Migraine
  • Focus Pharmacokinetics
  • Most Recent Events

    • 01 Nov 2009 Tolerability data reported in Headache.
    • 28 Jun 2008 Results presented at 50th Annual American Headache Society Meeting, Boston, Massachusetts, USA, 2008.
    • 26 Feb 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top